Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

21. Early Diagnosis in Children with Cerebral Palsy: Clinical Evidence and Guidelines

Early Diagnosis in Children with Cerebral Palsy: Clinical Evidence and Guidelines Early Diagnosis in Children with Cerebral Palsy: Clinical Evidence and Guidelines | CADTH.ca Find the information you need Early Diagnosis in Children with Cerebral Palsy: Clinical Evidence and Guidelines Early Diagnosis in Children with Cerebral Palsy: Clinical Evidence and Guidelines Published on: January 25, 2017 Project Number: RB1057-000 Product Line: Research Type: Other Diagnostics Report Type: Summary (...) of Abstracts Result type: Report Question What is the clinical evidence regarding early diagnosis in children with cerebral palsy? What are the evidence-based guidelines regarding early diagnosis in children with cerebral palsy? Key Message Four non-randomized studies were identified regarding early diagnosis in children with cerebral palsy. Tags cerebral palsy, diagnosis, cerebral palsies, diagnosis Files Rapid Response Summary of Abstracts Published : January 25, 2017 Follow us: © 2017 Canadian Agency

Canadian Agency for Drugs and Technologies in Health - Rapid Review2017

22. Interventions for Children with Cerebral Palsy: Guidelines

Interventions for Children with Cerebral Palsy: Guidelines Interventions for Children with Cerebral Palsy: Guidelines | CADTH.ca Find the information you need Interventions for Children with Cerebral Palsy: Guidelines Interventions for Children with Cerebral Palsy: Guidelines Published on: January 18, 2017 Project Number: RA0884-000 Product Line: Research Type: Other Diagnostics Report Type: Reference List Result type: Report Question What are the evidence-based guidelines regarding (...) interventions for children with cerebral palsy? Key Message No evidence-based guidelines were identified regarding interventions for children with cerebral palsy. Tags nervous system, pediatrics, cerebral palsy, spastic, diplegia, diplegias, cerebral palsies, Little disease, Little's disease Files Rapid Response Reference List Published : January 18, 2017 Follow us: © 2017 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

Canadian Agency for Drugs and Technologies in Health - Rapid Review2017

23. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.

Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. 28099276 2017 01 18 2017 01 18 1537-7385 96 2 2017 Feb American journal of physical medicine & rehabilitation Am J Phys Med Rehabil Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. 68-76 10.1097/PHM.0000000000000525 To assess the efficacy (...) and safety of botulinum toxin A (BoNT-A) injected in both submandibular and parotid versus only in parotid glands as a treatment for drooling in patients with spastic and dyskinetic cerebral palsy (CP), including an assessment of impact on quality of life (QoL) based on items from the International Classification of Functioning, Disability, and Health (ICF) core set. Forty patients with CP 18 years or older (mean, 21.8 years) participated in a prospective, single-center, randomized controlled

American journal of physical medicine & rehabilitation2017

26. Dance Improves Functionality and Psychosocial Adjustment in Cerebral Palsy: A Randomized Controlled Clinical Trial.

Dance Improves Functionality and Psychosocial Adjustment in Cerebral Palsy: A Randomized Controlled Clinical Trial. 27820729 2016 11 07 2017 05 18 1537-7385 96 6 2017 Jun American journal of physical medicine & rehabilitation Am J Phys Med Rehabil Dance Improves Functionality and Psychosocial Adjustment in Cerebral Palsy: A Randomized Controlled Clinical Trial. 424-429 10.1097/PHM.0000000000000646 This randomized controlled clinical trial aimed to investigate the effect of dance (...) in the functionality and psychosocial adjustment of young subjects with cerebral palsy (CP). Twenty-six young subjects with CP, GMFCS (Gross Motor Function Classification System) levels from II to V, were randomized into two intervention groups: kinesiotherapy and dance (n = 13 each). Twenty-four sessions (1 hour, twice a week) were performed in both groups. Functional Independence Measure (FIM) and World Health Organization Disability Assessment Schedule (WHODAS) by International Classification of Functioning

American journal of physical medicine & rehabilitation2016

27. Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases

Sialanar (glycopyrronium) - for treating severe drooling of saliva in children and adolescents (aged 3 years and above) with conditions affecting the nervous system, such as cerebral palsy, epilepsy and neurodegenerative diseases

European Medicines Agency - EPARs2016

28. Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment.

Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment. 27631386 2016 09 15 2017 03 16 1537-7385 96 4 2017 Apr American journal of physical medicine & rehabilitation Am J Phys Med Rehabil Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment. 221-225 10.1097/PHM (...) .0000000000000627 Physical therapy (PT) and botulinum toxin-A (BTX-A) injections are widely used in the treatment of spastic equinus foot due to cerebral palsy. The aim of this study was to show effects of intermittent serial casting (SC) in addition to standard treatment on spasticity, passive range of motion (PROM), and gait. Fifty-one ambulatory patients, treated by BTX-A to plantar flexor muscles, were randomly assigned to casting or control groups in a 2:1 ratio. Both groups received PT for 3 weeks

American journal of physical medicine & rehabilitation2016

29. Cerebral Palsy Integrated Pathway Scotland

Cerebral Palsy Integrated Pathway Scotland Cerebral Palsy Integrated Pathway Scotland (CPIPS) DVD | The Chartered Society of Physiotherapy Secondary links Search this site: User login Username or e-mail: * Password: * Keep me logged in (Don't choose this option on a shared computer) Don't have an account yet? Need help? Cerebral Palsy Integrated Pathway Scotland (CPIPS) DVD Children with cerebral palsy (CP) are at risk of developing musculoskeletal problems such as muscle contractures (...) of the surveillance programmes. Cerebral Palsy Integrated Pathway Scotland (CPIPS) has been implemented in Scotland as a pathway for a nationally agreed protocol of standardised musculoskeletal examination for children with CP to ensure equity throughout Scotland. It is based on best practice guidelines from Sweden and Australia and meets the principles of care recommended in the 2012 NICE Clinical Guideline ‘Spasticity in children and young people with non-progressive brain disorders’. APCP is campaigning

Chartered Society of Physiotherapy2016

30. Using Free Internet Videogames in Upper Extremity Motor Training for Children with Cerebral Palsy.

Using Free Internet Videogames in Upper Extremity Motor Training for Children with Cerebral Palsy. 27338485 2016 06 24 2016 06 24 2017 02 20 2076-328X 6 2 2016 Jun 07 Behavioral sciences (Basel, Switzerland) Behav Sci (Basel) Using Free Internet Videogames in Upper Extremity Motor Training for Children with Cerebral Palsy. 10.3390/bs6020010 E10 Movement therapy is one type of upper extremity intervention for children with cerebral palsy (CP) to improve function. It requires high-intensity (...) Trans Inf Technol Biomed. 2010 Mar;14(2):526-34 20071262 IEEE Int Conf Rehabil Robot. 2011;2011:5975432 22275633 Dev Med Child Neurol. 2006 Jul;48(7):549-54 16780622 IEEE Trans Neural Syst Rehabil Eng. 2001 Sep;9(3):308-18 11561668 J Rehabil Med. 2011 Mar;43(4):359-63 21347508 Dev Neurorehabil. 2010;13(5):335-45 20828330 Arch Phys Med Rehabil. 2010 Jan;91(1):1-8.e1 20103390 Pediatr Rehabil. 2002 Jul-Sep;5(3):141-8 12581476 PMC4931382 FAAST software Internet videogames Kinect cerebral palsy

Behavioral sciences (Basel, Switzerland)2016 Full Text: Link to full Text with Trip Pro

31. Prenatal Factors in Cerebral Palsy.

Prenatal Factors in Cerebral Palsy. Prenatal Factors in Cerebral Palsy. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26630148 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard (...) Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Dec 3;373(23):2288-9. doi: 10.1056/NEJMc1512559. Prenatal Factors in Cerebral Palsy. , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26630148 DOI: [Indexed for MEDLINE] Free full text Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text links You are here

NEJM2015

32. Prenatal Factors in Cerebral Palsy.

Prenatal Factors in Cerebral Palsy. Prenatal Factors in Cerebral Palsy. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26630149 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard (...) Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Dec 3;373(23):2288. doi: 10.1056/NEJMc1512559#SA1. Prenatal Factors in Cerebral Palsy. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26630149 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text links You are here

NEJM2015 Full Text: Link to full Text with Trip Pro

34. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy

Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy 26482662 2015 11 03 2016 02 11 2016 09 02 1098-4275 136 5 2015 Nov Pediatrics Pediatrics Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy. 895-904 10.1542/peds.2015-0749 To determine safety of intramuscular botulinum toxin A (BoNT-A) injections to reduce spasticity and improve care and comfort of nonambulatory children with cerebral palsy (CP). Nonambulatory children with CP were (...) procedure. There was no increased risk of moderate/serious AEs between one and two episodes of BoNT-A. Copyright © 2015 by the American Academy of Pediatrics. Edwards Priya P Queensland Paediatric Rehabilitation Service, Lady Cilento Children's Hospital, Brisbane Australia; Queensland Cerebral Palsy and Rehabilitation Research Centre, School of Medicine, The University of Queensland, priya.edwards@health.qld.gov.au. Sakzewski Leanne L Queensland Cerebral Palsy and Rehabilitation Research Centre, School

EvidenceUpdates2015

35. Intrathecal baclofen for treating spasticity in children with cerebral palsy.

Intrathecal baclofen for treating spasticity in children with cerebral palsy. BACKGROUND: Cerebral palsy is a disorder of movement and posture arising from a non-progressive lesion in the developing brain. Spasticity, a disorder of increased muscle tone, is the most common motor difficulty and is associated with activity limitation to varying degrees in mobility and self care.Oral baclofen, a gamma-aminobutyric acid (GABA) agonist, has been used in oral form to treat spasticity for some time (...) , but it has a variable effect on spasticity and the dose is limited by the unwanted effect of excessive sedation. Intrathecal baclofen produces higher local concentrations in cerebrospinal fluid at a fraction of the equivalent oral dose and avoids this excessive sedation. OBJECTIVES: To determine whether intrathecal baclofen is an effective treatment for spasticity in children with cerebral palsy. SEARCH METHODS: We searched the CENTRAL, MEDLINE, EMBASE and CINAHL databases, handsearched recent conference

Cochrane2015

36. Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness

Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness | CADTH.ca Find the information you need Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Active Video Gaming and Virtual Reality for Children with Cerebral Palsy: Sustained Clinical Effectiveness Published on: September 10 (...) , 2015 Project Number: RB0908-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the long-term clinical effectiveness of active video gaming (AVG) or virtual reality (VR) for children with cerebral palsy (CP)? Key Message One systematic review, three randomized controlled trials and two non-randomized studies were identified regarding the long-term clinical effectiveness of active video-gaming (AVG) or virtual reality (VR

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

37. Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness

Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness | CADTH.ca Find the information you need Functional Electrical Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Functional Electrical (...) Stimulation (FES) for Children with Spinal Cord Injuries or Cerebral Palsy : Update of Review of Clinical Effectiveness Published on: August 10, 2015 Project Number: RB0896-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of functional electrical stimulation (FES) including FES cycling (FES Cycle) for children with spinal cord injuries? What is the clinical effectiveness of functional electrical

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

38. Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy

Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy NIHR HSRIC Record Status This is a bibliographic record of a published health technology (...) assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Clostridium botulinum neurotoxin type A (Xeomin) for sialorrhoea associated with adult Parkinson's disease and paediatric cerebral palsy. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2015 Authors' objectives Clostridium botulinum neurotoxin type A (Xeomin) is a purified botulinum toxin type A, which acts as a neuromuscular blocking agent

Health Technology Assessment (HTA) Database.2015

39. Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy

Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy Oubiña M, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Oubiña M, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L. Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de

Health Technology Assessment (HTA) Database.2015

40. Sleep positioning systems for children with cerebral palsy.

Sleep positioning systems for children with cerebral palsy. BACKGROUND: Sleep positioning systems can be prescribed for children with cerebral palsy to help reduce or prevent hip migration, provide comfort to ease pain and/or improve sleep. As sleep disturbance is common in children with developmental disabilities, with impact on their carers' sleep, and as sleep positioning systems can be expensive, guidance is needed to support decisions as to their use. OBJECTIVES: To determine whether (...) commercially-available sleep positioning systems, compared with usual care, reduce or prevent hip migration in children with cerebral palsy. Any negative effect of sleep positioning systems on hip migration will be considered within this objective.Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip problems; (2) sleep patterns and quality; (3) quality of life of the child and family; (4) pain; and (5) physical functioning. We also sought

Cochrane2015